Zobrazeno 1 - 10
of 264
pro vyhledávání: '"A. Kalykaki"'
Publikováno v:
In Mechanisms of Ageing and Development December 2024 222
Autor:
M. Rovithi, A. G. Pallis, A. Kalykaki, E. Lagoudaki, L. Giannikaki, E. N. Stathopoulos, K. Relakis, V. Georgoulias
Publikováno v:
Case Reports in Medicine, Vol 2011 (2011)
Ovarian small cell carcinoma is a rare and highly malignant neoplasm carrying a poor prognosis. Although combination chemotherapy remains the cornerstone of treatment due to the rarity of these tumors, no regimen can be recommended as standard of car
Externí odkaz:
https://doaj.org/article/798c44fd42c94ebba84f70db7334293f
Autor:
Panagiotis Tirchas, Evangelos Pilios, Minas Achladianakis, Christina Kalafati Matthaiou, George Kossioris, Argyri Kyriakaki, Eleftherios Avgenikou, Panagiotis Paraschis, Maria Kalykaki, Nicholas Christakis, Michael Politis
Publikováno v:
International Journal of Neural Networks and Advanced Applications. 8:12-26
Covid-19 is the most recent strain from the corona virus family that its rapid spread across the globe has caused a pandemic, resulting in over 200,000,000 infections and over 4,000,000 deaths so far. Many countries had to impose full lockdowns, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8be1e7934f4318fe420a0b4a62b72b17
https://doi.org/10.46300/91016.2021.8.3
https://doi.org/10.46300/91016.2021.8.3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Drakoulis Yannoukakos, Despoina Kalfakakou, Nikolaos Androulakis, Paraskevi Apostolou, Sofia Agelaki, Elias Sanidas, Antonia Kalykaki, Christos Papadimitriou, Vassilis Georgoulias, Konstantinos Kalbakis, Lambros Vamvakas, Christos Christodoulou, Charalambos Kouroussis, Dimitris Mavroudis, Florentia Fostira, Irene Konstantopoulou, Angeliki Delimitsou, Emmanouil Saloustros
Publikováno v:
International Journal of Cancer. 147:1334-1342
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, the BRCA1/2 variant spect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc65d4db478ffe4347c7e147a3269b24
https://doi.org/10.1002/ijc.32903
https://doi.org/10.1002/ijc.32903
Autor:
Pallis, A.G. *, Karampeazis, A., Vamvakas, L., Vardakis, N., Kotsakis, A., Bozionelou, V., Kalykaki, A., Hatzidaki, D., Mavroudis, D., Georgoulias, V.
Publikováno v:
In Annals of Oncology November 2011 22(11):2448-2455
Autor:
Sofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, Maria A Papadaki, Galatea Kallergi, Dora Hatzidaki, Kostas Kalbakis, Dimitrios Mavroudis, Vassilis Georgoulias
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0123683 (2015)
To evaluate the efficacy of lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, in therapy-resistant HER2-positive CTCs in metastatic breast cancer (MBC).Patients with MBC and HER2-positive CTCs despite disease stabilization or response to pri
Externí odkaz:
https://doaj.org/article/cd3e9bf174ff4b51adb459ccbc06d601
Autor:
Z. Saridaki, Evaghelos Xynos, John Souglakos, Nikolaos Gouvas, Aristea Kalykaki, Alexandra Voutsina, Maria Tzardi, Maria Sfakianaki, Telenia Kalambaliki, Ioannis Boukovinas, Athanasios Athanasiadis
Publikováno v:
Forum of Clinical Oncology, Vol 9, Iss 1, Pp 31-36 (2019)
Introduction Several studies show that mutational profiles could influence treatment decisions in patients with metastatic CRC (mCRC). KRAS mutational status was the first step in biomarkers development in the era of molecular targeted therapies. Rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76894da0e25b07545fc568dd46d021c2
https://doi.org/10.2478/fco-2018-0005
https://doi.org/10.2478/fco-2018-0005
Autor:
K. Yiangou, A. Hadjisavvas, S. Agelaki, D. Aggouraki, N. Androulakis, V. Bozionelou, I. Drositis, K. Kalmpakis, A. Kalykaki, E. Kontopodis, A. Kotsakis, E. Politaki, G. Saloustrou, L. Vamvakas, N.K. Vardakis, V. Georgoulias, D. Mavroudis, K. Michailidou, E. Saloustros
Publikováno v:
Annals of Oncology. 33:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e7d2dd263b48ee7dcb93aa3444e471f
https://doi.org/10.1016/j.annonc.2022.03.166
https://doi.org/10.1016/j.annonc.2022.03.166
Autor:
Pallis, A.G., Agelaki, S., Kakolyris, S., Kotsakis, A., Kalykaki, A., Vardakis, N., Papakotoulas, P., Agelidou, A., Geroyianni, A., Agelidou, M., Hatzidaki, D., Mavroudis, D., Georgoulias, V.
Publikováno v:
In Lung Cancer 2008 62(3):356-363